Cell counting is the technique of counting cells in pharmaceutical, biotechnology, and other clinical & medical research operations for a variety of medicinal purposes. Cell counts are used to calculate the number of cells per volume in liquid media. The cell counting method required to determine additional operations requires multiple treatments. When conducting research and experimentation, cell counting makes it easier to maintain cell cultures and aids in the preparation of cells for transfection and subsequent studies.
The market for cell counting in 2021 was USD 10.48 billion and will be worth USD 19.27 billion by 2030 at a 7% CAGR during 2021-2030.
Cell counting techniques are becoming increasingly popular as the incidence of numerous chronic diseases, such as cancer, HIV-AIDS, leukemia, Alzheimer's disease, etc., rises. The development of next-generation medicines is also accelerating the market expansion as more medical specialties, including molecular biology, immunology, pathology, etc., are adopting cell counting tools.
Market Dynamics
Drivers
- The rising prevalence of target diseases like HIV, measles, diphtheria, chronic conditions like cancer, hemophilia, and other blood disorders, is what fuels the worldwide cell counting industry. By the end of 2020, the World Health Organization predicts that close to 37.7 million people will be living with HIV worldwide. In addition, 680,000 people passed away in 2020 from HIV-related causes, and 1.5 million more are at risk of contracting the disease in the years to come. Therefore, rising infectious disease instances will fuel the industry's rapid expansion.
- Additionally, technological advancements in cell counting tools or reagents have increased product launches, fueling the market's expansion. For instance, the DeNovix Inc. product The CellDrop, an automated cell counter that enables researchers to count cells without using slides, won the Best New Life Science Product of the Year Award on May 19, 2020.
Restraints
The high cost of complex cell counting technologies, a lack of skilled workers, and product recalls involving haematology analyzers restrain the growth of the global cell counting industry.
Opportunity
The rising rate of chronic blood disorders will drive the growth of the global market for cell counting. As per a study in 2020, the incidence rate of leukaemia worldwide is 274,519 with 311, 549 death due to the disease. Because of these disorders high fatality and prevalence, the rate of adoption will increase, resulting in market growth in the future.
Market Segmentation
Product Insights
In 2021, consumables and accessories contributed for more than 50.0% of total revenue. Reagents, microplates, magnetic beads, and chamber slides are some of the consumables and accessories utilized with these gadgets. Their high usage volume is a contributing factor in the expansion of consumables and accessories. Additionally, the introduction of innovative items spurs market expansion.
Application Insights
In 2021, complete blood count had the highest revenue share of 55.0%. The complete blood count is frequent test to assess a person's general health. The test measures several blood components, including RBC, WBC, hemoglobin, hematocrit, and platelets. The growing prevalence of blood illnesses, including leukemia and anemia, which complete blood counts frequently monitor, will fuel segment growth.
End-Use Insights
Academic and research institutions led the entire market with the largest share of 35.0% in 2021. The widespread use of cytometers in cell biology research investigations can be blamed for the large share. Researchers use cytometers to measure criteria like physical characteristics, kind, and lineage to track the evolution of viruses, diseases, and other bacteria. The segment is further driven by strategic actions taken by major market participants.
Regional Insights
Due to the growing emphasis on biomedical and cancer research, North America held the greatest revenue share of about 35.0% in 2021. One of the key factors influencing the use of these devices is the rise in the prevalence of chronic diseases, such as blood and cardiovascular disorders. According to the American National Red Cross, 90,000 to 100,000 Americans are affected by sickle cell disease.
Asia Pacific regional market will increase exponentially. This region's clinical research and biopharmaceutical business concentration can be blamed for the exponential CAGR. In addition, the region's market is primarily driven by the aging geriatric population, which is extremely sensitive to chronic ailments.
Key Players
- PerkinElmer Inc
- Olympus Corporation
- Thermo Fisher Scientific Inc
- Merck KGaA
- HORIBA Ltd
- Tecan Trading AG
- Abbott
- Logos Biosystems Inc
- Corning Incorporated
- General Electric Company
- Tip Biosystems
- Agilent Technologies Inc
- Sysmex Corporation
- Boule Diagnostics AB
- Becton, Dickinson, and Company
- Siemens Healthcare Private Limited
- Diconex
- ChemoMetec A/S
- Bio-Rad Laboratories Inc
- R&D Systems, Inc.
- Beckman Coulter Inc
- Nexcelom Bioscience LLC
- Advanced Instruments
- Cole-Parmer Instrument Company LLC
The market for cell counting in 2021 was USD 10.48 billion and will be worth USD 19.27 billion by 2030 at a 7% CAGR during 2021-2030. Market expansion is due to the rising demand for biologics to treat chronic diseases. The use of various cell counting tools during biologics development, including flow cytometers and spectrophotometers, helps manage cell concentration in biologics and boosts the market's growth prospects.
UpMarketResearch offers a latest published report on “Global Cell Counting Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.
It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.
Cell Counting market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
The global cell counting market is projected to reach USD 14.5 billion in 2025 from USD 10.4 billion in 2020, at a CAGR of 6.7 % during the forecast period.Cell Counting Market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers.On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.By application, the research application segment accounted for the largest share of the cell counting market On the basis of application, the cell counting market is segmented into research, medical, and industrial applications.
In 2019, research applications accounted for the largest share of the market.
Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728By end user, the research institutes segment accounted for the largest share of the cell counting market On the basis of end users, the cell counting market is segmented into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users.
In 2019, research institutes accounted for the largest share of the market.
The large share of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R expenditure, and commercial expansion of various pharmaceutical companies.By region, North America accounted for the largest share of the cell counting market In 2019, North America accounted for the largest share of the cell counting consumables market, followed by Europe.
The large share of the North American market can be attributed to the increasing demand for technologically advanced instruments in research and diagnostic applications and the high prevalence of target conditions, coupled with the increasing demand for early and effective disease diagnosis and treatment.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728Leading Players The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US)
Cell Counting Industry Overview:Goal to offer most segmented consumption and sales data of several types of Cell Counting Market, downstream consumption fields, and competitive landscape in numerous regions and countries around the globe, this report studies the latest upcoming market data from the primary and secondary authoritative foundation.The market is fueled to grow due to various factors in the American, European, and APAC regions.
However, the Middle East and African markets are yet to be explored by the market players.
The Middle East and African regional market are lagging owing to a lack of awareness among researchers, high cost of instruments and consumables among other factors.
However, the regions of Africa are burdened with the disease caused by a virus, bacteria, and parasites, such as malaria, dengue, swine flu, and influenza where the market products provide huge support in diagnostics.
Thus, these present a lucrative opportunity for the market players in these regions.The report also suggests the latest market dynamics, such as key driving factors, key restraining factors, and industry news such as mergers, acquisitions, and investments.
It provides market size (value and volume), industry share, market growth rate by types, applications, end-user and combines both qualitative and quantitative techniques to make micro and macro predictions in numerous regions or countries in the world.The global cell counting market valued at USD 9765.2 million in 2019 and is expected to grow at a 6.5% CAGR during the forecast period.Our Report Will Help You Find What You Looking for.
